NCT05672706 A Study of Pressure Waveform Analysis in Coronary Artery-II
| NCT ID | NCT05672706 |
| Status | Recruiting |
| Phase | — |
| Sponsor | National Taiwan University Hospital Hsin-Chu Branch |
| Condition | Ischemic Heart Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 30 participants |
| Start Date | 2023-01-04 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 30 participants in total. It began in 2023-01-04 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this observational study is to test the feasibility of intracoronary adenosine administration during coronary flow reserve(CFR) and index of microcirculatory resistance(IMR) assessment in a population with angina. The main questions it aims to answer are: * Repeatability of CFR and IMR assessment while hyperemia with intracoronary adenosine was administered. * Evaluate the correlation of the intrinsic signal of coronary waveform versus physiologic ischemia, while defined by fractional flow reserve(FFR) and CFR respectively. * The predictive value of FFR, CFR, and IMR on major adverse cardiovascular outcomes in 3 years Participants will undergo FFR, CFR, and IMR assessments in the catheterization laboratory of the National Taiwan University Hospital Hsin-Chu Branch, then clinical events follow up for 3 years.
Eligibility Criteria
Inclusion Criteria: * Participants with angina Exclusion Criteria: * Severe valvular heart disease * History of asthma * Heart rate less than 50 beats per minute * systolic blood pressure less than 90 mmHg
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05672706 clinical trial?
This trial is open to participants of all sexes, aged 21 Years or older, studying Ischemic Heart Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05672706 currently recruiting?
Yes, NCT05672706 is actively recruiting participants. Contact the research team at jgboon0407@gmail.com for enrollment information.
Where is the NCT05672706 trial being conducted?
This trial is being conducted at Hsinchu, Taiwan.
Who is sponsoring the NCT05672706 clinical trial?
NCT05672706 is sponsored by National Taiwan University Hospital Hsin-Chu Branch. The trial plans to enroll 30 participants.